Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Chan

Showing results (471-480 of 509) with videos related to

Pageof 51
Sort By:
Oncogene|February 29, 2012
Conditional activation of Pik3ca(H1047R) in a knock-in mouse model promotes mammary tumorigenesis and emergence of mutationsW Yuan, E Stawiski, V Janakiraman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 14, 2016
Randomized phase II study of modified FOLFOX-6 in combination with ramucirumab or icrucumab as second-line therapy in patients with metastatic colorectal cancer after disease progression on first-line irinotecan-based therapyM Moore, S Gill, T Asmis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2021
Long-term Follow-up and Patterns of Response, Progression, and Hyperprogression in Patients after PD-1 Blockade in Advanced SarcomaNicholas D Klemen, Sinchun Hwang, Martina Bradic, et al.
Obesity (Silver Spring, Md.)|February 7, 2023
A two-decade population-based study on the effect of hypertension in the general population with obesity in the United StatesGwyneth Kong, Yip H Chin, Jieyu Lim, et al.
Journal for Immunotherapy of Cancer|April 2, 2022
Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single centerEvan Rosenbaum, Cristina R Antonescu, Shaleigh Smith, et al.
Medrxiv : the Preprint Server for Health Sciences|August 19, 2022
Who is pregnant? defining real-world data-based pregnancy episodes in the National COVID Cohort Collaborative (N3C)Sara Jones, Katie R Bradwell, Lauren E Chan, et al.
JAMA Dermatology|July 8, 2026
ctDNA or Merkel Virus Antibodies for Surveillance of Merkel Cell Carcinoma RecurrenceManisha Thakuria, Tomoko Akaike, Ann W Silk, et al.
Prostate Cancer and Prostatic Diseases|November 2, 2025
DARolutamide ObservationaL (DAROL) study in patients with nonmetastatic castration-resistant prostate cancer: prespecified third interim analysisEvan Y Yu, Hiroyoshi Suzuki, Christopher M Pieczonka, et al.
Journal for Immunotherapy of Cancer|September 5, 2025
High transposable element expression in sarcomas is associated with increased immune infiltrates and improved outcomes including after immunotherapyBenjamin A Nacev, Martina Bradic, Hyung Jun Woo, et al.
The Journal of Experimental Medicine|November 7, 2001
Functional cloning of Src-like adapter protein-2 (SLAP-2), a novel inhibitor of antigen receptor signalingS J Holland, X C Liao, M K Mendenhall, et al.
Pageof 51

Showing results (471-480 of 509) with videos related to

Sort By:
Pageof 51
Oncogene|February 29, 2012
Conditional activation of Pik3ca(H1047R) in a knock-in mouse model promotes mammary tumorigenesis and emergence of mutationsW Yuan, E Stawiski, V Janakiraman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 14, 2016
Randomized phase II study of modified FOLFOX-6 in combination with ramucirumab or icrucumab as second-line therapy in patients with metastatic colorectal cancer after disease progression on first-line irinotecan-based therapyM Moore, S Gill, T Asmis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2021
Long-term Follow-up and Patterns of Response, Progression, and Hyperprogression in Patients after PD-1 Blockade in Advanced SarcomaNicholas D Klemen, Sinchun Hwang, Martina Bradic, et al.
Obesity (Silver Spring, Md.)|February 7, 2023
A two-decade population-based study on the effect of hypertension in the general population with obesity in the United StatesGwyneth Kong, Yip H Chin, Jieyu Lim, et al.
Journal for Immunotherapy of Cancer|April 2, 2022
Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single centerEvan Rosenbaum, Cristina R Antonescu, Shaleigh Smith, et al.
Medrxiv : the Preprint Server for Health Sciences|August 19, 2022
Who is pregnant? defining real-world data-based pregnancy episodes in the National COVID Cohort Collaborative (N3C)Sara Jones, Katie R Bradwell, Lauren E Chan, et al.
JAMA Dermatology|July 8, 2026
ctDNA or Merkel Virus Antibodies for Surveillance of Merkel Cell Carcinoma RecurrenceManisha Thakuria, Tomoko Akaike, Ann W Silk, et al.
Prostate Cancer and Prostatic Diseases|November 2, 2025
DARolutamide ObservationaL (DAROL) study in patients with nonmetastatic castration-resistant prostate cancer: prespecified third interim analysisEvan Y Yu, Hiroyoshi Suzuki, Christopher M Pieczonka, et al.
Journal for Immunotherapy of Cancer|September 5, 2025
High transposable element expression in sarcomas is associated with increased immune infiltrates and improved outcomes including after immunotherapyBenjamin A Nacev, Martina Bradic, Hyung Jun Woo, et al.
The Journal of Experimental Medicine|November 7, 2001
Functional cloning of Src-like adapter protein-2 (SLAP-2), a novel inhibitor of antigen receptor signalingS J Holland, X C Liao, M K Mendenhall, et al.
Pageof 51